A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Clinical trial NCT07047690 · RECRUITING

Trial details

NCT number: NCT07047690
Sponsor: Galderma R&D
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis

Start date: 2026-02-20
Primary completion: 2028-05-28
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.